PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Ayaka Hogg explains the mysteries behind neurodegeneration caused by prions, misfolded proteins that can spread through the brain.
Megan Perry reviews the developments in cystic fibrosis treatment, including the revolution precision medicine is having on patient outcomes.
By Rhian Gruar This article was originally published in The Oxford Scientist Michaelmas Term 2021 edition, Change. On the 26 June 2000, President Bill Clinton announced the completion of the first draft of the Human Genome Project (HGP) to the world, ushering in a new age of scientific understanding. The HGP was a decade-long endeavour…